fMRI study on effect of NK1 antagonist (Aprepitant) on cognitive function in normal subjects
Not Applicable
- Conditions
- Substance-related disorders, Mood disorders, Anxiety disorders
- Registration Number
- JPRN-UMIN000004381
- Lead Sponsor
- ippon Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
patients with psychiatric disorder patients with hepatic, kidney, cardiac disorders patients taking other drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison between placebo and Aprepitant conditions.
- Secondary Outcome Measures
Name Time Method